Effectiveness of aromatherapy using Rosa damascene oil on severity of premenstrual syndrome among Palestinian female students randomized clinical trial

Phase 1

• Conditions: premenstrual syndrome among Palestinian femalestudents; aromatherapy Rosa damascene oil premenstrual syndrome female

• Registration Number: TCTR20220420001
• Lead Sponsor: ebanon Clinical Trials Registry

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2022-04-20
• Study Completion: 2022-06-30
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Pending (Not yet recruiting)
• Sex: Female
• Target Recruitment: 80

Inclusion Criteria

Inclusion Criteria include the females undergraduate students age 18 years and above
from An-Najah National university and Palestine Technical University.
Inclusion criteria for phase 2 particularly: presence of PMS symptoms ( mild,
moderate or severe), with low score of depression, anxiety or stress according to the
DASS cut off points and scoring manual.

Exclusion Criteria

Exclusion criteria included the subjects with any of the followings
1. Irregular menses: menstrual cycle intervals (<24 or >35 days)
2. Allergy to aromatherapy
3. Starting hormone therapy or using medication that mataffect the treatment
4. Not using hormone medication for at least 2 months before
5. married

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
primary outcome- effect on PMS 0 - 3 months scale: mean difference

Secondary Outcome Measures

Name	Time	Method
secondary outcome- depression , anxiety and stress 0-3 months changes of the mean (DASS)